Latest updates

New Clinical Trial for Treatment in Prostate Cancer Patients with Specific Genetic Biomarkers

September 30, 2021

MiraDx, in collaboration with the UCLA Jonsson Comprehensive Cancer Center, is conducting a clinical trial to validate a novel prostate cancer biomarker panel designed to help assess patients who were at a greater risk of having long-term toxicity in response to their radiation treatment, to help guide treatment decisions. Treatment can involve radiation therapy, surgery, and/or hormone therapy Radiation has […]

Read More


CLIA certified and CAP Accredited Lab Address

Administrative Address

11601 Wilshire Blvd., Suite 2410, Los Angeles, CA, 90025